BACIL PHARMA LTD. Share Price

BACIL PHARMA LTD. Share Price

BSE: 524516
|
Pharmaceuticals
|
S Cap
₹ 20.34
+₹0.96 (4.95%)
1D
Last updated 15 Sep, 2026, 13:37 IST

BACIL PHARMA LTD. Share Price Today

As of 15 Sep 2026, BACIL PHARMA LTD. share price is ₹20.34. The stock opened at ₹20.34, compared to its previous close of ₹19.38. During today's trading session, BACIL PHARMA LTD. share price moved in the range of ₹20.00 to ₹20.34, with an average price of ₹20.17 for the day. Looking at its last 52-week, the stock has touched a low of ₹10.65 and a high of ₹61.80.

₹20.00
4.95% up today
₹20.34
1D LOW
1D HIGH

BACIL PHARMA LTD. Returns Calculator

Circuit
L
H
₹18.42
₹20.34
52-week
L
H
₹10.65
₹61.80

About BACIL PHARMA LTD.

BACIL PHARMA LTD. Share Price
ISIN
INE711D01018
Sector Market Cap
₹ 27.82 Cr

Bacil Pharma Limited is an India-based pharmaceutical company, which is engaged in the business of manufacturing of pharmaceuticals, medicinal chemicals and botanical products. The Company operates as a manufacturer, exporter, supplier and retailer of a range of anti-anxiety medicine, antihistamines, chemical compound, drugs, and herbal tablets and capsules.

BACIL PHARMA LTD. Financial Highlights

  • Revenue: BACIL PHARMA LTD. reported revenue of ₹1.24 crore in FY26 vs ₹0.66 crore in FY25. It showed an increase of 87.88% on a yearly basis.
  • Operating Profit: BACIL PHARMA LTD. reported an operating profit of ₹0.99 crore in FY26 vs ₹0.41 crore in FY25. It showed an increase of 141.46% on a year-on-year basis.
  • Net Profit: BACIL PHARMA LTD. reported a net profit of ₹1.56 crore in FY26 vs ₹0.40 crore in FY25. It showed an increase of 290.00% on a yearly basis.

BACIL PHARMA LTD. Quarterly Result Highlights

  • BACIL PHARMA LTD. reported revenue of ₹0.09 crore in Jun 2026, compared with ₹0.11 crore in Mar 2026, representing a decrease of 18.18% on a quarter-on-quarter (QoQ) basis.
  • BACIL PHARMA LTD. reported an operating profit of ₹0.07 crore in Jun 2026, compared with ₹0.04 crore in Mar 2026, representing an increase of 75.00% on a quarter-on-quarter (QoQ) basis.
  • BACIL PHARMA LTD. reported a loss of ₹0.02 crore in Jun 2026, compared with ₹0.62 crore in Mar 2026, reflecting a decrease of 103.23% on a QoQ basis.
  • The earnings per share (EPS) of BACIL PHARMA LTD. stood at ₹1.11 during Jun 2026.

Data Source: BSE, Company announcements

Securities shown are illustrative, not recommendations. Past performance does not guarantee future results.

Know more
Promoters
0.00%
FII
0.00%
Other DII
0.00%
Retail and other
100.00%
Mutual funds
0.00%
Foreign Institutional Investor (FII)
FII shareholding by period
Sep 20250.00%
Dec 20250.00%
Mar 20260.00%
Jun 20260.00%
Mkt Cap Cr
27.82
P/E
42.13
P/B
1.10
ROE
6.27%
D/E
0.00
ROCE
3.99%
Div. Yield
0.00%
EPS(TTM)
1.11
Turnover
0.00
EV/EBITDA
160.30
Net Margin
0.00%
Op. Margin
0.00%
ROA
2.37%
Quick Ratio
0.68
Curr. Ratio
0.68
Based on fundamentals, this stock's
Step 5 of 5
Performance
Excellent
Bacil Pharma outperforming all market indices
Step 1 of 5
Valuation
Overvalued
Bacil Pharma appears overvalued compared to its peers
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROED/EROCEBook ValueDiv. YieldTurnoverEPS(TTM)
Sun Pharmaceutical Industries4,41,958.0036.485.2913.74%0.6117.33%93.240.87%0.4810.90
Divis Laboratories2,47,576.0084.6414.7715.32%0.0019.56%629.490.32%0.5598.19
Torrent Pharmaceuticals1,89,233.0087.7722.5025.49%1.6913.85%222.760.68%0.4958.70
Zydus Lifesciences1,11,671.0024.324.1218.59%0.3117.35%237.300.09%0.3335.38
Cipla1,10,273.0032.863.2011.27%0.0014.95%423.360.95%0.4543.52
Laurus Labs1,06,460.0097.6420.0916.77%0.4016.14%97.200.10%0.6713.72
Dr. Reddy's Laboratories96,906.4030.442.5511.07%0.1812.54%377.950.69%0.4138.68
Aurobindo Pharma96,401.7025.982.549.25%0.1911.76%394.820.24%0.3841.58
Lupin95,842.9017.274.2723.76%0.0424.88%659.000.86%0.57129.18
Mankind Pharma94,050.4045.495.7711.74%0.3413.13%396.980.04%0.4449.37

Auto-generated based on historical fundamentals; not a recommendation to buy/sell.

BACIL PHARMA LTD. Financials

Full statement

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹0.00₹0.00₹0.00₹0.00
Other Income₹1.24₹0.66₹0.13₹0.11
Total Revenue₹1.24₹0.66₹0.13₹0.11
Total Expenses₹0.25₹0.25₹0.19₹0.22
Profit Before Tax₹0.99₹0.41-₹0.06-₹0.10
Tax-₹0.57₹0.00₹0.00₹0.00
Profit After Tax₹1.56₹0.40-₹0.06-₹0.10
EPS - Basic₹1.11₹0.64-₹0.10-₹0.17
EPS - Diluted₹1.11₹0.64-₹0.10-₹0.17

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax₹0.04₹0.41-₹0.06-₹0.10
Income before WC changes-₹0.53₹0.38-₹0.09-₹0.13
Change in Assets-₹1.13-₹0.04₹0.00₹0.00
Change in Liabilities₹2.37₹0.06₹0.09-₹0.02
Change in WC₹1.24₹0.02₹0.08-₹0.02
Cash flow from Operations₹0.71₹0.40₹0.00-₹0.15
Cash flow from Investing-₹2.38₹0.34₹0.08-₹0.12
Cash flow from Financing-₹0.62₹2.08-₹0.06₹0.06
Total Cash Flow-₹2.29₹2.82₹0.01-₹0.20
Cash (Start of the year)₹2.86₹0.04₹0.03₹0.23
Cash (End of the year)₹0.57₹2.86₹0.04₹0.03

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹25.64₹22.69₹1.27₹0.90
Current Assets₹1.75₹2.91₹0.05₹0.23
Total Assets₹27.39₹25.60₹1.33₹1.13
Current Liabilities₹2.58₹0.17₹0.11₹0.03
Net Current Asset-₹0.83₹2.74-₹0.06₹0.20
Non-Current Liabilities₹0.00₹0.00₹0.00₹0.00
Equity Capital₹24.81₹25.43₹1.21₹1.10
Total Equity & Liabilities₹27.39₹25.60₹1.33₹1.13
* All values are in INR Crore
Qty
Bid
9134
20.34
2010
20.1
1500
20.09
2500
20.08
2500
20.07
Ask
Qty
0
0
0
0
0
0
0
0
0
0
Bid Total: 17644
Ask Total: 0
Buy orders: 100%
Sell orders: 0%
Bearish
5
Neutral
2
Bullish
1
Neutral
by SEBI experts
Expert Pick
EXPPICK
Stop-loss
Entry price
Target
Indicator
Value
Verdict
RSI (14)
62.34
Neutral
ATR (14)
0.91
Neutral
STOCH(9,6)
100
Bearish
STOCH RSI (14)
100
Bearish
ADX(9)
50.46
Bearish
UO(9)
88.27
Bearish
ROC(12)
66.78
Bullish
WillR(14)
0
Bearish
Period
Simple value
Exponential vaue
5D
17.69
17.76
10D
15.81
16.38
20D
13.79
16.04
50D
21.97
21.87
100D
35.92
29.91
Volume trend — traded volume by day
15 Sep1L
11 Sep0L
10 Sep1L
9 Sep0L
8 Sep0L
Average0L

Technical indicators used here are for indicative purposes only. Kindly do not treat it as an investment or trading advice

Compare against other stocks
BACIL PHARMA LTD. Share Price
BACIL PHARMA LTD.
Pharmaceuticals
Add Stock
Add Another

BACIL PHARMA LTD. Share Price FAQs

BACIL PHARMA LTD. share price data is sourced from NSE/BSE and may be delayed. It is displayed for informational purposes only and does not constitute investment advice or a recommendation to buy or sell.

Trusted by 2 Crore+ Indians for their wealth-building needs. SEBI Registered Broker. SEBI Reg No. INZ000315837